Insufficient scRNA-seq data for expression of RMI1 at single-cell level.
Insufficient scRNA-seq data for expression of RMI1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 425.18 | 1442 / 1445 | 100% | 23.46 | 183 / 183 |
brain | 100% | 422.68 | 2633 / 2642 | 100% | 17.02 | 702 / 705 |
breast | 100% | 319.66 | 458 / 459 | 99% | 23.92 | 1109 / 1118 |
prostate | 100% | 425.25 | 245 / 245 | 98% | 22.01 | 493 / 502 |
lung | 98% | 323.17 | 569 / 578 | 100% | 17.91 | 1151 / 1155 |
ovary | 99% | 283.47 | 178 / 180 | 99% | 15.81 | 424 / 430 |
stomach | 99% | 368.11 | 354 / 359 | 98% | 16.31 | 281 / 286 |
intestine | 100% | 382.20 | 962 / 966 | 97% | 16.06 | 511 / 527 |
uterus | 98% | 253.46 | 167 / 170 | 98% | 22.47 | 450 / 459 |
bladder | 100% | 311.48 | 21 / 21 | 95% | 15.63 | 480 / 504 |
thymus | 100% | 449.14 | 653 / 653 | 95% | 11.05 | 574 / 605 |
pancreas | 100% | 364.04 | 328 / 328 | 94% | 10.08 | 168 / 178 |
adrenal gland | 99% | 719.50 | 255 / 258 | 87% | 12.22 | 201 / 230 |
skin | 100% | 574.66 | 1800 / 1809 | 85% | 9.43 | 400 / 472 |
kidney | 99% | 261.18 | 88 / 89 | 84% | 7.94 | 758 / 901 |
liver | 100% | 267.01 | 225 / 226 | 77% | 7.22 | 311 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.59 | 29 / 29 |
spleen | 100% | 773.55 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 28.52 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.90 | 1 / 1 |
adipose | 99% | 280.16 | 1194 / 1204 | 0% | 0 | 0 / 0 |
muscle | 98% | 296.37 | 790 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 90% | 154.32 | 1205 / 1335 | 0% | 0 | 0 / 0 |
heart | 89% | 206.30 | 765 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 75% | 552.94 | 697 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 29% | 1.61 | 23 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000724 | Biological process | double-strand break repair via homologous recombination |
GO_0035264 | Biological process | multicellular organism growth |
GO_0071139 | Biological process | resolution of DNA recombination intermediates |
GO_0006260 | Biological process | DNA replication |
GO_0009749 | Biological process | response to glucose |
GO_0002023 | Biological process | reduction of food intake in response to dietary excess |
GO_0042593 | Biological process | glucose homeostasis |
GO_0000712 | Biological process | resolution of meiotic recombination intermediates |
GO_0016604 | Cellular component | nuclear body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0031422 | Cellular component | RecQ family helicase-topoisomerase III complex |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0000166 | Molecular function | nucleotide binding |
Gene name | RMI1 |
Protein name | RecQ-mediated genome instability protein 1 RecQ-mediated genome instability protein 1 (BLM-associated protein of 75 kDa) (BLAP75) (FAAP75) |
Synonyms | C9orf76 |
Description | FUNCTION: Essential component of the RMI complex, a complex that plays an important role in the processing of homologous recombination intermediates to limit DNA crossover formation in cells. Promotes TOP3A binding to double Holliday junctions (DHJ) and hence stimulates TOP3A-mediated dissolution. Required for BLM phosphorylation during mitosis. Within the BLM complex, required for BLM and TOP3A stability. . |
Accessions | A0A0A0MSU3 ENST00000325875.7 Q9H9A7 ENST00000445877.6 ENST00000445877 |